Online weight loss drug dangers flagged by Outgoing USFDA chief
Wahington: Outgoing U.S. Food and Drug Administration (USFDA) Commissioner Robert Califf stated on Thursday that existing laws and regulations are not enough to protect Americans from the dangers posed by compounded versions of popular weight loss drugs, particularly those purchased online.
Califf emphasized that the issue would be less severe if the original drugs were more affordable, as he noted during a media roundtable with reporters.
According to Reuters, Califf said, "I'm very worried about the internet compounding industry. Some of it, I'm sure, is very high quality, but it's very hard, if you are ordering things on the internet, to know exactly what you're getting,"
"If the price of these drugs was not so high, it wouldn't be such a problem."
Novo Nordisk' and Eli Lilly's weight loss drugs can cost over $1,000 for a month's supply, while compounded versions typically cost a few hundred dollars.
The FDA needs more support, Califf said. His comments contrast with those of Trump's nominee for health secretary, Robert F. Kennedy Jr., who has said the agency's department in charge of nutrition labels on food has "to go" because it was not protecting Americans.
"Look at food side; it's massively underfunded and if you're also saying you want to radically change the food system, that will be a problem," Califf said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.